NCT04400396

Brief Summary

It is reported that the standard method for fortification of human milk (HM) overestimates the energy and protein densities of HM (Macedo MHNP 2018), thus originating infant undernutrition (Macedo AJP 2018). The target fortification, based on analysis of HM composition, is considered the gold-standard method (Rochow 2015, McLeod 2016). This observational mixed cohort study aims to assess if very preterm infants fed HM with target fortification have greater growth during hospital stay and better body composition at term post-menstrual age (PMA), than those fed HM with standard fortification.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 22, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2021

Completed
Last Updated

June 9, 2020

Status Verified

June 1, 2020

Enrollment Period

1.4 years

First QC Date

May 18, 2020

Last Update Submit

June 5, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • weight gain velocity rate

    average relative daily variation of body weight

    from baseline (the first day of exclusive or predominantly feeding with fortified human milk) up to 40 weeks postmenstrual age or to home discharge, whatever comes first

  • length velocity rate

    average relative weekly variation of body length

    from baseline (the first day of exclusive or predominantly feeding with fortified human milk) up to 40 weeks postmenstrual age or to home discharge, whatever comes first

  • head circumference velocity rate

    average relative weekly variation of head circumference

    from baseline (the first day of exclusive or predominantly feeding with fortified human milk) up to 40 weeks postmenstrual age or to home discharge, whatever comes first

  • adiposity (fat mass index)

    ratio of fat mass over squared body length

    A single measurement performed up to 10 days after home discharge

Secondary Outcomes (1)

  • adiposity (fat mass percentage)

    A single measurement performed up to 10 days after home discharge

Study Arms (2)

target HM fortification

Contemporary cohort fed HM with target fortification

Dietary Supplement: target HM fortification

standard HM fortification

Historical cohort fed HM with standard fortification

Dietary Supplement: standard HM fortification

Interventions

standard HM fortificationDIETARY_SUPPLEMENT

Based on the assumed energy and macronutrient composition of HM, the commercial multi-component HM fortifier was added, in order to compensate identified nutritional deficits.

standard HM fortification
target HM fortificationDIETARY_SUPPLEMENT

Based on the measured energy and macronutrient composition of HM, modular protein and fat supplements are added, in addition to the commercial multi-component HM fortifier, in order to correct identified specific nutritional deficits. For this purpose, an Excel program to calculate modular protein and fat supplements to be added to fortified HM was developed and registered (Nona R, Cardoso M, Portuguese Directorate of Intellectual Property Services, IGAC-DSPI, nº 480/2020, 26 February 2020)

target HM fortification

Eligibility Criteria

Age1 Day+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Very preterm newborn infants (born at \<33 weeks) that achieve full enteral feeding exclusively or predominantly with human milk

You may qualify if:

  • newborn infants born at \<33 weeks of gestation,
  • admitted to the NICU of Maternidade Dr. Alfredo da Costa (inborns and outborns),
  • exclusively or predominantly HM fed (\>87.5% volume per day)
  • discharged alive.

You may not qualify if:

  • multiples of grade \>2
  • diagnosis of innate metabolism disorder,
  • fed with formula for \>12.5% of the daily volume intake for two or more consecutive full days ,
  • discharge with transference to other hospital,
  • unavailable for body composition analysis after discharge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar Universitário de Lisboa Central

Lisbon, 1150-199, Portugal

Location

Related Publications (9)

  • Macedo I, Pereira-da-Silva L, Cardoso M. The fortification method relying on assumed human milk composition overestimates the actual energy and macronutrient intakes in very preterm infants. Matern Health Neonatol Perinatol. 2018 Sep 17;4:22. doi: 10.1186/s40748-018-0090-4. eCollection 2018.

    PMID: 30237896BACKGROUND
  • McLeod G, Sherriff J, Hartmann PE, Nathan E, Geddes D, Simmer K. Comparing different methods of human breast milk fortification using measured v. assumed macronutrient composition to target reference growth: a randomised controlled trial. Br J Nutr. 2016 Feb 14;115(3):431-9. doi: 10.1017/S0007114515004614. Epub 2015 Dec 2.

    PMID: 26627899BACKGROUND
  • Rochow N, Landau-Crangle E, Fusch C. Challenges in breast milk fortification for preterm infants. Curr Opin Clin Nutr Metab Care. 2015 May;18(3):276-84. doi: 10.1097/MCO.0000000000000167.

    PMID: 25807355BACKGROUND
  • Macedo I, Pereira-da-Silva L, Cardoso M. Associations of Measured Protein and Energy Intakes with Growth and Adiposity in Human Milk-Fed Preterm Infants at Term Postmenstrual Age: A Cohort Study. Am J Perinatol. 2018 Jul;35(9):882-891. doi: 10.1055/s-0038-1626717. Epub 2018 Feb 2.

  • Henriksen C, Westerberg AC, Ronnestad A, Nakstad B, Veierod MB, Drevon CA, Iversen PO. Growth and nutrient intake among very-low-birth-weight infants fed fortified human milk during hospitalisation. Br J Nutr. 2009 Oct;102(8):1179-86. doi: 10.1017/S0007114509371755. Epub 2009 May 18.

  • Maas C, Wiechers C, Bernhard W, Poets CF, Franz AR. Early feeding of fortified breast milk and in-hospital-growth in very premature infants: a retrospective cohort analysis. BMC Pediatr. 2013 Nov 4;13:178. doi: 10.1186/1471-2431-13-178.

  • Morlacchi L, Mallardi D, Gianni ML, Roggero P, Amato O, Piemontese P, Consonni D, Mosca F. Is targeted fortification of human breast milk an optimal nutrition strategy for preterm infants? An interventional study. J Transl Med. 2016 Jul 1;14(1):195. doi: 10.1186/s12967-016-0957-y.

  • Polberger S. New approaches to optimizing early diets. Nestle Nutr Workshop Ser Pediatr Program. 2009;63:195-204; discussion 204-8, 259-68. doi: 10.1159/000209982.

  • Cardoso M, Virella D, Macedo I, Silva D, Pereira-da-Silva L. Customized Human Milk Fortification Based on Measured Human Milk Composition to Improve the Quality of Growth in Very Preterm Infants: A Mixed-Cohort Study Protocol. Int J Environ Res Public Health. 2021 Jan 19;18(2):823. doi: 10.3390/ijerph18020823.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Human milk (HM), including mother's own milk (MOM) and donor's milk (DHM).

MeSH Terms

Conditions

Premature BirthBreast Milk ExpressionFeeding BehaviorObesity

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBreast FeedingBehaviorBehavior, AnimalOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Luis Pereira-da-Silva, MD, PhD

    Universidade Nova de Lisboa

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2020

First Posted

May 22, 2020

Study Start

February 1, 2020

Primary Completion

June 30, 2021

Study Completion

December 16, 2021

Last Updated

June 9, 2020

Record last verified: 2020-06

Locations